Panel Informativity Optimizer (PIO): an R package to improve cancer NGS panel informativity
Abstract
Mutation detection by next generation sequencing (NGS) is routinely used for cancer diagnosis. Selecting an optimal set of genes for a given cancer is not trivial as it has to optimize informativity (i.e. the number of patients with at least one mutation in the panel), while minimizing panel length in order to reduce sequencing costs and increase sensitivity. We propose herein Panel Informativity Optimizer (PIO), an open-source software developed as an R package with a user-friendly graphical interface to help optimize cancer NGS panel informativity. Using patient-level mutational data from either private datasets or preloaded dataset of 91 independent cohort from 31 different cancer type, PIO selects an optimal set of genomic intervals to maximize informativity and panel size in a given cancer type. Different options are offered such as the definition of genomic intervals at the gene or exon level, and the use of optimization strategy at the patient or patient per kilobase level. PIO can also propose an optimal set of genomic intervals to increase informativity of custom panels. A panel tester function is also available for panel benchmarking. Using public databases, as well as data from real-life settings, we demonstrate that PIO allows panel size reduction of up to 1000kb, and accurately predicts the performance of custom or commercial panels. PIO is available online at https://vincentalcazer.shinyapps.io/Panel_informativity_optimizer/ or can be set on a locale machine from https://github.com/VincentAlcazer/PIO.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- FWCI
- 0.11
- Field percentile
- 29th percentile
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Targeted mutation detection in breast cancer using MammaSeqTM
N. G. Smith, R. Gyanchandani, … A. V. Lee·bioRxiv·Feb 13, 2018
- Development of an electronic decision aid tool to facilitate mainstream genetic testing in ovarian cancer patients
Kristen Mahoney Shannon, Devanshi Patel, … Karen Sepucha·The OncologistPeer-reviewed·Nov 30, 2023
- A Computational Workflow for Analysis of Missense Mutations in Precision Oncology
Rayyan Tariq Khan, Petra Pokorná, … David Bednář·Journal of CheminformaticsPeer-reviewed·Jul 29, 2024
- Achieving reproducibility and accuracy in cancer mutation detection with whole-genome and whole-exome sequencing
Wenming Xiao, Luyao Ren, … Leming M. Shi·Nature BiotechnologyPeer-reviewed·Sep 1, 2021
- Analysis of Mutations in Precision Oncology using The Automated, Accurate, and User-Friendly Web Tool PredictONCO
Rayyan Tariq Khan, Petra Pokorná, … David Bednář·Computational and Structural Biotechnology JournalPeer-reviewed·Nov 14, 2024
- Accurate somatic variant calling performance using Avidity Sequencing with Burning Rock OncoScreenTM Plus panel
Guangliang Zhang, Yangyang Liu, … Zhihong Zhang·bioRxiv·Sep 20, 2023